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Purpose: It was hypothesized that heparan sulfate (HS) as an essential compound for myogenesis 
and nanoparticles of gold (nano-Au) as highly reactive compounds can affect muscle development 
as a consequence of molecular regulation of muscle cell formation, and that these effects may 
be enhanced by a complex of HS conjugated with nano-Au. The objective of the present study 
was to determine the effect of administration of nano-Au, HS, and a nano-Au+HS complex on 
the morphological and molecular characteristics of breast muscle during embryogenesis.
Methods: Chicken embryos were used as in vivo model. Fertilized chicken eggs (n = 350) 
were randomly divided into the control group and the groups treated with nano-Au, HS, and 
nano-Au+HS. The experimental solutions were given in ovo on the first day of incubation and 
the embryos were evaluated on day 20 of incubation. The methods included biochemical indi-
ces in blood, immunohistochemistry, microscopy (transmission electron microscopy, scanning 
electron microscopy, confocal), and gene expression at the messenger ribonucleic acid and 
protein levels.
Results: The treatments did not adversely affect mortality, organ weight, and homeostasis of 
the embryos. HS stimulated the development and maturation of breast muscle by increasing the 
number of nuclei, satellite cells, and muscle fibers and affected the expression of basic fibroblast 
growth factor-2 and paired-box transcription factor-7. Furthermore, the nano-Au+HS complex 
contributed to the increased number of myocytes and nuclei in chicken embryo muscles.
Conclusion: The results indicate that the administration of HS and nano-Au affects muscle 
development and that this effect is enhanced by conjugating HS with nano-Au.
Keywords: gold nanoparticles, heparan sulfate, muscle development, embryogenesis, chicken
Introduction
Myogenesis is the key process of muscle development occurring during embryogenesis, 
with the final number of muscle cells nearly established just before birth.   Myogenesis 
begins with the conversion of pluripotent cells into myoblast precursors, which, depend-
ing on extracellular signals, undergo migration or proliferation. Afterwards, the precur-
sors stop dividing and some form uninuclear totipotential cells, ie, satellite cells, while 
the remaining myoblasts begin to differentiate. Subsequently, they undergo fusion to 
form multinucleated myotubes, which become muscle cells. The process of formation 
of muscle is almost completed at the time of hatching, and the numbers of muscle fibers 
and nuclei in muscle cells are almost fixed.1,2 Satellite cells are potentially mitotically 
active myogenic cells, located at the periphery of muscle fibers, between the sarcolemma 
and the basement membrane of developed muscle fibers. In contrast to muscle cells, 
satellite cells retain the capacity for DNA   replication and mitotic division, and have International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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the ability to proliferate in response to muscle damage, hence 
they support the process of muscle regeneration in postnatal 
life.3 In the muscles of birds, satellite cells appear between 
day 13 and day 16 of embryogenesis.4
The factor responsible for renewing the pool of satellite 
cells is the protein paired-box transcription factor-7 (Pax-7).1 
It affects the transcriptional activation of genes and regulates 
the development of myogenic cells.5 In Pax-7-deficient neo-
natal mice, a lack of satellite cells in crossstriated skeletal 
muscles was observed, suggesting that this is a key factor 
responsible for the formation of satellite cells,6 and is there-
fore an excellent marker of satellite cell development.7
During embryogenesis, the activity of myoblasts and satel-
lite cells is highly affected by the extracellular matrix, consist-
ing of an organized network of proteins and polysaccharides 
(collagen, proteoglycans, and glycoproteins).2 Proteoglycans 
play an important role in the differentiation of muscle, regu-
lating the reactivity of myoblasts and satellite cells by acting 
on basic fibroblast growth factor-2 (FGF-2) and the family of 
transforming growth factors.8 The interaction between muscle 
cells and FGF-2 depends on several factors, including the pres-
ence of heparan sulfate (HS) in the extracellular matrix. HS 
mediates interactions with a variety of extracellular ligands and 
participates in the proliferation, differentiation, migration, and 
adhesion of cells.9 The genetic capacity for proper development 
of muscle tissue in embryos of animals and humans may be 
hampered by a shortage of sulfur signaling compounds in the 
extracellular matrix, especially glycosaminoglycans.10
The unique properties of gold nanoparticles (nano-Au) 
are due to their small size, much larger surface area per unit 
mass compared with larger particles, and a greater proportion 
of atoms exposed on the surface of the particles, making them 
much more reactive than larger particles.11 Nano-Au exhibit 
a strong affinity for thiol groups, which allows efficient and 
selective bonding with intracellular compounds.12 Nano-Au 
can penetrate cells by endocytosis, and they can be carriers 
of pharmaceuticals, nucleic acids, and other biologically 
active substances.13,14 The application of drugs conjugated 
with nano-Au has shown high precision in the delivery of 
drugs, and significantly decreased their doses.15
It has been demonstrated that low concentrations of nano-Au 
are not toxic to human cells,16 but cause toxicity in zebrafish17 
and when using higher doses deposited in animal tissues.18 The 
present experiment was not designed to evaluate potential toxic-
ity of nano-Au but to measure their effects on muscle develop-
ment when used in a small concentration (50 mg/L solution).
Nano-Au can create biocomplexes with organic com-
pounds in the process of self-assembly (self-organization) 
using noncovalent bonds.19,20 The phenomenon of self-
organization allows the creation of new structures in a 
simple and natural way, and in this respect, nano-Au seem 
to be a promising candidate for self-assembly processing of 
biomolecules like HS.
It was hypothesized that HS as an essential compound for 
myogenesis and nano-Au as highly reactive compounds can 
affect muscle development as a consequence of molecular 
regulation of muscle cell formation, and that these effects 
may be enhanced by a complex of HS conjugated with 
nano-Au. The objective of the present study was to deter-
mine the effect of administration of HS, nano-Au, and the 
nano-Au+HS complex on the morphological and molecular 
characteristics of muscle development, particularly on the 
number of muscle and satellite cells.
Materials and methods
solutions
The hydrocolloid of nano-Au (50 mg/L) obtained from 
Nano-Tech (Warsaw, Poland) was produced by an electric 
nonexplosive patented method (Polish patent 3883399) from 
high purity metals (99.99%) and high purity demineralized 
water. The structure of the nanoparticles was visualized 
by a JEM-1220 transmission electron microscope (TEM) 
(JEOL, Tokyo, Japan) and the diameter ranged from 5–70 nm 
(  Figure 1). HS was provided by Iduron Ltd (Manchester, 
United Kingdom) as a K5 polysaccharide derivative. 
  Produced in Escherichia coli K5, it has a repeat unit   structure 
identical to the nonsulfated regions of HS. The highly 
  sulfated derivative was applied where sulfation was carried 
out by chemical and enzymatic methods. This polymer was 
N-sulfated, O-sulfated at C-6 of α-N-sulfo-D-glucosamine, 
C2 and C3 of glucuronic acid, and had variable O-sulfation 
at C3 of α-N-sulfo-D-glucosamine.
HS was conjugated with nano-Au by mixing the HS water 
solution (0.032 mg/L) with nano-Au hydrocolloid (50 mg/L) 
in an ultrasonic bath (Sonorex Super RK 514 H; Bandelin 
Electronic, Berlin, Germany) for 30 minutes at 36°C at a 
frequency of 50/60 Hz.
experiment
Fertilized chicken eggs (n = 350) were randomly divided into 
four treatment groups: (1) control group (without injection), 
(2) nano-Au group (with nano-Au solution), (3) HS group 
(with HS solution), and (4) nano-Au+HS group (with mixture 
of nano-Au and HS). The experimental solutions were given 
in ovo on the first day of incubation by injecting 500 µL of 
each solution into the air sack.International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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The embryos were evaluated on day 20 of incubation. The 
embryos were weighed together with the yolk sack, decapi-
tated, and blood samples from the carotid artery were with-
drawn and collected in Eppendorf polymerase chain reaction 
(PCR) tubes (Eppendorf AG, Hamburg, Germany). Samples 
were incubated at room temperature until clotting and then 
centrifuged for 10 minutes (14,500 × g). The resulting blood 
serum samples were stored at −30°C until further analysis. 
The liver, heart, and spleen were collected and weighed. 
Samples of the breast muscles (4 × 6 × 2 mm) were collected 
in liquid nitrogen for immunohistochemistry, enzyme-linked 
immunosorbent assay, and confocal microscopy preparations 
or fixed in glutaraldehyde for electron microscopy prepara-
tion or collected in RNAlater® ribonucleic acid (RNA) Sta-
bilization Solution (Applied Biosystems/Ambion, Austin, 
TX) for gene expression analysis.
The experimental procedures were approved by, and com-
plied with the guidelines of, the National Ethical Committee 
of Animal Experimentation, Poland.
Analytical methods
evaluation of embryo development
Embryo  development  was  evaluated  on  day  20  of 
embryogenesis. The morphological structure was compared 
with the standard described by Hamburger and Hamiliton.21
Concentrations of magnesium, calcium, phosphorus, 
triglycerides, cholesterol in very-low-density lipoprotein, 
glucose, and the activities of aspartate aminotransferase, 
alanine aminotransferase, alkaline phosphatase, and lac-
tate dehydrogenase in blood serum were measured by dry 
chemistry methods using the chemical analyzer Johnson 
and Johnson Vitros® DT60 II (Ortho-Clinical Diagnostics 
Inc, Raritan, NJ).
Immunohistochemistry
Frozen (−80°C) breast muscles were cut on a cryostat 
(Leica CM1900; Leica Microsystems GmbH, Wetzlar, 
Germany) into 7 µm thick sections and put on microscopic 
slides covered with poly-L-lysine (Waldemaar Knittel 
Gläsbearbeitungs, Braunschweig, Germany). Fixation was 
performed in 4% paraformaldehyde for 30 minutes and then 
in 0.5% Tween® 20 (Bio-Rad Laboratories, Hercules, CA) 
for 5 minutes. Fixed slides were kept at −20°C until further 
processing.
Specimens were hydrated with 10 minutes incubation 
in phosphate buffered saline (PBS; Sigma-Aldrich Corpo-
ration, St Louis, MO) at room temperature. Staining was 
performed in the dark, using a solution containing 1 µg/mL 
4′,6-diamidino-2-phenylindole (DAPI; Sigma-Aldrich) in 
PBS. The incubation lasted for 20 minutes and was followed 
Figure 1 Image of hydrocolloid of gold nanoparticles visualized using transmission electron microscopy.International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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by a triple rinse of the slides with PBS. The specimens were 
then coverslipped using ProLong® Gold Antifade Reagent 
(Life Technologies, Carlsbad, CA).
Fixed preparations were hydrated for 10 minutes in PBS 
at room temperature. Specimens were then incubated in a 
solution containing 2% goat serum (Sigma-Aldrich) and 
1% bovine serum albumin (Sigma-Aldrich) for 20 minutes 
at room temperature to block nonspecific binding. In the 
next step, the specimens were incubated with the primary 
antibody (Pax-7; Santa Cruz Biotechnology, Inc, Santa 
Cruz, CA) diluted 1:200 for 60 minutes at room temperature. 
Subsequently, excess antibodies were washed off with 
three rinses of PBS and the secondary antibody (antimouse 
immunoglobulin G–fluorescein isothiocyanate antibody 
  produced in goat; Sigma-Aldrich) diluted 1:1000 was applied. 
After a triple rinse of the slides in PBS, DAPI staining was 
performed.
Microscopy
Immunohistochemically stained specimens were visualized 
using a FluoView FV-1000 confocal microscope equipped 
with FV10-ASW version 1.4. software (Olympus Corpora-
tion, Warsaw, Poland). The pictures were analyzed using the 
cellSens® Dimension program (Olympus).
The breast muscles were examined using a Quanta™ 
200 scanning electron microscope (SEM; FEI Company, 
Hillsboro, OR), using environmental SEM operating mode 
and by TEM. For observations with SEM, samples were 
stored at −30°C. Frozen (−30°C) samples were cleanly cut 
with a scalpel into 1 mm thick sections on frozen pieces of 
wax. While still frozen, a sample section was placed on a 
Peltier table within a standard cooled microscope column (at 
−5°C for blood vessels and −10°C for cartilage) in the sample 
chamber under high vacuum (10−5 Torr). For observations 
with TEM, immediately after dissection, tissues were cut into 
pieces of about 1 mm3 and fixed in a 2.5% glutaraldehyde 
solution (Sigma-Aldrich) in 0.1 M phosphate buffer (pH 6.9). 
Samples were then rinsed in the same buffer and transferred 
to a 1% osmium tetroxide solution (Sigma-Aldrich) in 
0.1 M phosphate buffer (pH 6.9) for 1 hour. Subsequently, 
the samples were rinsed in distilled water, dehydrated in an 
ethanol gradient, and impregnated with epoxy embedding 
resin (Fluka Epoxy Embedding Medium Kit; Sigma-Aldrich). 
The next day, samples were embedded in the same resin and 
baked for 24 hours at 36°C. The blocks were then transferred 
to a 60°C incubator and baked for another 24 hours. The 
blocks were cut into ultrathin sections (50–80 nm) using 
an ultramicrotome (Ultratome III; LKB Products, Bromma, 
Sweden) and transferred onto copper grids, 200 mesh 
(Agar Scientific Ltd, Stansted, Essex, United Kingdom). 
  Subsequently, the sections were contrasted using uranyl 
acetate dihydrate (Sigma Aldrich) and lead citrate (lead (II) 
citrate tribasic trihydrate; Sigma-Aldrich).
gene expression of Pax-7 and FGF-2 at messenger 
rNA (mrNA) level
The tissue dissected from the breast muscle was homogenized 
in TRIzol® Reagent (Life Technologies), and total RNA 
was extracted according to the manufacturer’s instructions. 
The RNA samples were purified, using the SV Total RNA 
Isolation System (Promega Corporation, Madison, WI) and 
quantified using a NanoDrop ND 1000 spectrophotometer 
(Thermo Fisher Scientific, Waltham, MA). Using reverse 
transcriptase with oligo(dT) (Promega) and random prim-
ers (TAG Copenhagen A/S, Copenhagen, Denmark), 2 mg 
of total RNA was reverse transcribed, after which real-time 
PCR was performed with complementary DNA and gene-
specific primer pairs (TAG Copenhagen; Table 1) mixed with 
LightCycler®480 SYBR Green I Master mix (Roche Applied 
Science, Penzberg, Germany) in a LightCycler®480 Real-
Time PCR system (Roche Applied Science). The samples 
were first denatured for 5 minutes at 95°C and then ampli-
fied using 45 cycles of 10 seconds at 95°C (denaturation), 
10 seconds at 60°C–62°C (annealing), and 9 seconds at 
72°C (elongation), followed by quantification. A melting 
curve program (56°C–97°C with a heating rate of 0.11°C/
second and five acquisitions per 1°C) was applied to verify 
the specificity of the product. For each complementary DNA, 
the reaction was performed in   triplicate. For analyses, relative 
quantification was applied with ACTB and EEF1-α used as 
the housekeeping genes.
gene expression of FGF-2 at protein level
Frozen breast muscle tissue samples were homogenized 
on ice using RIPA lysis and extraction buffer (Thermo 
Table 1   Oligonucleotide  sequences  used  in  polymerase  chain 
reaction
Gene Size Primer sequences (5′ to 3′)
ACTB ca. 169 bp Forward: gTc cAc cTT ccA gcA gAT gT
reverse: ATA AAg ccA Tgc cAA TcT cg
EEF1-α ca. 85 bp Forward: Agc AgA cTT TgT gAc cTT gcc
reverse: TgA cAT gAg AcA gAc ggT Tgc
FGF-2 ca. 151 bp Forward: ggc AcT gAA ATg Tgc AAc Ag
reverse: Tcc Agg Tcc AgT TTT Tgg Tc
PAX-7 ca. 135 bp Forward: ccA gTA gAg AcA ggc cAA gc
reverse: ggA gTT ggg AAg gAg TAg ggInternational Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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Fisher Scientific) and a Polytron® PT 2100 homogenizer 
(  Kinematica AG, Lucerne, Switzerland). Homogenates were 
left on ice for 30 minutes and were subsequently centrifuged 
for 20 minutes (4°C, 12,500 rpm). The supernatant was 
collected in chilled Eppendorf PCR tubes (Eppendorf AG). 
Supernatant samples were divided into two equal portions. 
One was used to evaluate the total protein concentration 
(Total Protein Kit, Micro Lowry, Peterson’s Modification; 
Sigma-Aldrich). The second portion was used to perform 
the enzyme-linked immunosorbent test, using an Enzyme-
linked Immunosorbent Assay Kit for Gallinaceous FGF-2 
(USCN Life Science, Tokyo, Japan). Reagents and plates 
were prepared accordingly to the manufacturer’s standard 
procedure and incubated for 25 minutes under standard 
conditions. The degree of absorption was measured in a 
microplate reader Infinite® M200 PRO (Tecan Deutschland 
GmbH, Crailsheim, Germany).
statistical analysis
Statistical analysis of data was carried out using a two-way 
analysis of variance test (Statgraphics Plus version 4.1; Stat-
Point Technologies, Inc, Warrenton, VA). The model included 
two factors (nano-Au and HS treatments) and interactions 
between the factors. Significant effects were stated when 
P , 0.05.
Results
In the present experiment, embryos treated with HS had 
lower mortality than other groups. Nano-Au, HS, and 
nano-Au+HS complex did not affect embryo weight or the 
weight of organs, except for the heart being slightly smaller 
with HS treatment (Table 2). Furthermore, there was no 
significant effect on the measured biochemical indices in 
blood (Table 3).
To examine the influence of nano-Au and HS on muscle 
development, the number of nuclei was determined (DAPI 
staining) in the breast muscle, showing increased number of 
nuclei in treated embryos (Figure 2). The counted number 
of nuclei was significantly higher in embryos treated with 
nano-Au and nano-Au+HS than in the control group, and 
there was highly significant interaction between nano-Au 
and HS treatments (Table 4).
Breast muscle tissue was visualized by SEM, using the 
environmental SEM operating mode which allows observa-
tion with minimal distortion to the muscle structure. There 
were visual changes in the structure of the breast muscle in 
the groups treated with injections compared to the embryos 
from the control group (Figure 3). In the control group, the 
muscle fibers formed the most compact structure and the 
surface of individual muscle fascicles was smaller compared 
to the treatment groups. Furthermore, the distances between 
fascicles were greater and the area of fascicles was longer 
with sharper structures in the control group than in the treat-
ment groups. Empty areas, which were seen around fascicles 
in the control group, were much smaller than in the treatment 
groups. In embryos treated with nano-Au, HS, and nano-
Au+HS, muscle fibers were organized in more rounded and 
well-developed fascicles, located equally within muscle. In 
the HS-treated groups, the connective tissue seen between 
muscle fascicles was better developed than in the other 
embryos. The structure of the muscle cross-section in the 
nano-Au+HS group was the most homogeneous and mature. 
Fascicles were the most rounded and filled with myofibers. 
The space around them also showed better connective tissue 
structure.
The evaluation of the morphology of breast muscles 
was carried out using TEM. While analyzing transverse 
section images of muscle samples from the control group, 
an enlargement area was seen between cells and cells were 
more rounded and less angular with a slightly stippled 
cytoplasm. Within cells, cylindrical myofibrils were seen; 
however, in the control group they were loosely spaced 
with larger spaces between myofibers than in the treatment 
groups. Also, myomere decay, unification of actin and 
Table 2 Mortality and average weight of embryos and organs without (–) or with gold nanoparticles and heparan sulfate
Treatment ANOVA
Without HS With HS Effect Interaction
– Nano-Au – Nano-Au Nano-Au HS P
P SEM P SEM
Mortality, % 13.6 15.6 9.52 8.33
embryo, % e.w 85.1 84.9 85.0 85.0 0.615 0.29 0.917 0.26 0.045
Liver, % b.w 1.66 1.75 1.72 1.69 0.074 0.030 0.447 0.029 0.613
heart, % b.w 0.60 0.59 0.63 0.56 0.347 0.011 0.002 0.013 0.099
spleen, % b.w 0.05 0.04 0.05 0.04 0.066 0.002 0.094 0.002 0.844
Abbreviations: % e.w, % of egg weight; % b.w, % of body weight; ANOVA, analysis of variance; hs, heparan sulfate; nano-Au, gold nanoparticles; seM, standard error of the mean.International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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myosin filaments, loose connective tissue, and occasional 
myelin structures were observed (Figure 4). Muscles from 
the nano-Au group were characterized by contracted cells 
and bigger myocytes. In the muscles from the HS group, a 
higher number of satellite muscle cells were seen. Moreover, 
angular, homogeneous myofibers were observed close to 
each other. These muscles were more developed compared 
with the control group. In the muscles from the nano-Au+HS 
group, homogenous and closely located (packed) muscle 
cells were seen. Within cells, myofilaments were clearly 
seen and numerous mitochondria and a large number of 
satellite cells were also observed.
From the morphometric measurements, the number of 
satellite cells and muscle cells were determined (Table 4). HS 
and nano-Au+HS increased the number of muscle cells and 
satellite cells, compared to the control and nano-Au groups.
To confirm the effects on the number of satellite cells, 
muscle samples were stained for Pax-7 protein and observed 
with a confocal microscope (Figure 5). The muscles from 
embryos treated with HS and nano-Au+HS had a larger 
number of clusters of Pax-7 protein than the muscles from 
the nano-Au and control groups.
To confirm the results on the molecular level, gene expres-
sion of Pax-7 and FGF-2 in the breast muscle was measured 
(Table 5). At the mRNA level, HS significantly increased 
expression of Pax-7 and significantly reduced the expression 
of FGF-2. However, there was no effect of nano-Au and no 
interaction between nano-Au and HS.
Discussion
In the present study, the chicken embryo was chosen as the 
animal model. It has a rapid rate of growth and its embry-
onic development is described in detail.21 The embryo 
is independent from the mother,22 it is highly sensitive 
to harmful factors,23 and it has been used as a suitable 
model for cancer therapy research,24 the determination of 
bacterial invasiveness,25 and new drug delivery systems 
development.26
Analysis of the present results led to the conclusion that 
administration of nano-Au, HS, and nano-Au+HS did not 
negatively affect the growth and development of chicken 
embryos. The results from other investigations suggest that, 
up to a certain concentration, nano-Au are not harmful to an 
organism, but with increasing concentrations they may have 
harmful effects.16–18,27,28 The present study was not undertaken 
to evaluate potential toxicity of nano-Au, however, it con-
firmed the lack of harmful effects of nano-Au administered 
in small quantities (concentration: 50 mg/L, dose: 500 µL). 
Nano-Au did not negatively affect development of embryos 
Table 3 Biochemical indices in the blood serum of chicken embryos without (–) or with gold nanoparticles and heparan sulfate
Treatment ANOVA
Without HS With HS Effect Interaction
– Nano-Au – Nano-Au Nano-Au HS  P
P SEM P SEM
Magnesium (mmol/L) 0.75 0.88 0.75 0.88 0.702 0.516 0.477 0.129 0.882
calcium (mmol/L) 2.70 2.71 2.45 2.96 0.980 0.136 0.092 0.038 0.752
Phosphorus (mmol/L) 1.73 1.69 1.71 1.70 0.651 0.060 0.916 0.059 0.751
Triglycerides (mmol/L) 0.78 0.75 0.79 0.73 0.714 0.062 0.529 0.062 0.962
cholesterol-VLDL (mmol/L) 0.35 0.35 0.36 0.34 0.904 0.039 0.740 0.036 0.928
glucose (mmol/L) 10.6 10.2 10.1 10.2 0.502 0.51 0.689 0.507 0.899
Alkaline phosphatase (U/L) 658 636 567 727 0.812 64.2 0.093 54.2 0.620
Aspartate aminotransferase (U/L) 144 162 181 125 0.512 19.2 0.050 29.2 0.138
Alanine aminotransferase (U/L) 11.7 10.2 13.2 8.70 0.527 1.707 0.075 1.88 0.839
Lactate dehydrogenase (U/L) 2720 3047 2945 2822 0.223 184.2 0.643 192.3 0.399
Abbreviations: ANOVA, analysis of variance; hs, heparan sulfate; nano-Au, gold nanoparticles; seM, standard error of the mean; VLDL, very-low-density lipoprotein.
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Figure 2 Images of nuclei (blue), stained with 4′,6-diamidino-2-phenylindole, in the 
cross-section of the breast muscle of a chicken embryo on day 20 of incubation 
visualized  using  a  confocal  microscope.  (A)  control,  (B)  gold  nanoparticles,   
(C) heparan sulfate, and (D) gold nanoparticles and heparan sulfate complex.International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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(mortality, organ weight, and homeostasis). Nevertheless, 
the present results are from a short term study over 20 days 
of embryogenesis; because nano-Au can penetrate most 
tissues,29–31 their potentially negative effects may take place 
later in life.
In comparison to Au, HS is a natural component of tissues 
and given at the concentration of 0.032 mg/L and the dose 
of 500 µL had no adverse effects on embryonic develop-
ment; moreover, HS reduced the mortality of embryos and 
decreased the heart weight compared to the other groups. 
The heart develops from cardiomyocyte precursors and 
even at the beginning of embryogenesis works together with 
the developing outer network of blood vessels.22 According 
to Ausprunk,32 HS is involved in the differentiation and 
development of arterial and venous vessels of the chorioal-
lantoic membrane. A key factor for vascular development is 
vascular endothelial growth factor.33 HS can partially acti-
vate an inactive form of vascular endothelial growth factor, 
prolonging its biological activity.34 Furthermore, addition 
of a sulfated oligosaccharide enhances angiogenesis and 
stabilizes the capillary network of new blood vessels.10,35 
Thus, a properly developed system of blood vessels of the 
correct diameter may decrease the resistance of peripheral 
vessels and, consequently, slightly decrease the force of heart 
contractions, leading to a proper heart weight. It should also 
be noted that the activity of alanine aminotransferase, aspar-
tate aminotransferase, and other biochemical parameters of 
blood did not change, which otherwise could be the sign of 
distortion in the homeostasis of the organism, including the 
circulatory system.
Assessing the dynamics of muscle development, it was 
found that the total number of DAPI-labeled nuclei increased 
after in ovo HS injection, indicating enhanced dynamics of 
embryonic muscle development. Within the muscle tissue of 
the developing chicken embryo, nuclei of various cells can be 
observed: multinuclear muscle cells, connective tissue cells, 
blood cells, nerve cells, satellite cells, and other stem cells, 
but the muscle cells and muscle stem cells are dominant.2 
AB
CD
5 µm 5 µm
5 µm 5 µm
Figure 4 Images of the ultrastructure of the cross-section of the breast muscle of 
a chicken embryo on day 20 of incubation visualized using transmission electron 
microscopy. (A) control, (B) gold nanoparticles, (C) heparan sulfate, and (D) gold 
nanoparticles and heparan sulfate complex.
Table 4 Morphometry of the breast muscle of chicken embryos without (–) or with gold nanoparticles and heparan sulfate
Treatment ANOVA
Without HS With HS Effect Interaction
– Nano-Au – Nano-Au Nano-Au HS P
P SEM P SEM
Number of myocytes/10,000 µm2* 23.0 27.5 18.5 32.1 0.197 3.21 0.0000 2.88 0.024
Number of satellite cells/10,000 µm2* 7.1 8.4 6.8 8.7 0.213 0.91 0.0330 0.72 0.452
Fiber area (µm2)* 19.9 25.0 19.2 21.4 0.002 1.06 0.0007 1.30 0.023
Number of nuclei/10,000 µm2** 16.1 19.7 15.7 21.4 0.004 0.84 0.0009 1.03 0.0009
Notes: *Transmission electron microscope; **confocal microscope.
Abbreviations: ANOVA, analysis of variance; hs, heparan sulfate; nano-Au, gold nanoparticles; seM, standard error of the mean.
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Figure 3 Images of the ultrastructure of the cross-section of the breast muscle of a 
chicken embryo on day 20 of incubation visualized using scanning electron microscopy 
(environmental scanning electron microscope mode). (A) control, (B) gold nanoparticles, 
(C) heparan sulfate, and (D) gold nanoparticles and heparan sulfate complex.International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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The analysis of images obtained from SEM and TEM clearly 
showed an increase in the number of muscle cells after treatment 
with HS. To explain this phenomenon, two mechanisms could 
be considered; the first may indicate a scarcity of HS, which is 
essential for muscle development while the second may point 
to the stimulating effects of HS. In the present experiment, 
morphological defects seen in the control group may confirm 
the first mechanism that the quantity of HS or it precursors 
in the egg was not sufficient for optimal muscle development.
The mechanism of formation of muscle structures, depend-
ing on the chemical composition of the extracellular matrix, is 
not fully known. Myogenesis starts early in embryonic devel-
opment and FGF-2 plays a key role in mesoderm induction.36 
This factor stimulates proliferation and inhibits cell differen-
tiation37 by suppressing the transcription of myogenin.38 HS 
allows cells to bind FGF-2 and with an increasing number 
of sulfur groups, the binding efficiency increases,39,40 while 
a loss of sulfur groups blocks glycosaminoglycan activity.41 
Inhibition of proliferation because of HS deficiency and 
premature cell differentiation is likely to reduce the number 
of cells in the final stages of embryonic development and 
ultimately may lead to defective tissue structure, especially 
in intensively growing organisms.42,43
In the present experiment, expression of FGF-2 at the 
mRNA level in the HS groups decreased more than fourfold 
compared to the control group. The evaluation of morphologi-
cal and molecular indices of muscle development was carried 
out at day 20 of incubation, hence at the end of embryogenesis, 
just before hatching. On day 20 of embryonic development, 
the process of muscle development is almost finished and the 
number of muscle cells is almost stable. This was manifested 
by the reduced expression of FGF-2 at mRNA level in HS 
muscles, indicating that the process of muscle fiber forma-
tion was completed. At the protein level, the concentration of 
FGF-2 protein was not significantly affected by HS, probably 
because protein expression occurs as a consequence of gene 
expression and is associated with a delay.
The effect of HS on FGF-2 expression at the mRNA 
level may be explained by an increased affinity of FGF-2 
for its receptor,44–46 thereby enhancing the FGF/FGF receptor 
interaction. It has also been demonstrated that both HS and 
heparin may increase the surface concentration of FGF-2, 
as well as assist in ligand dimerisation;46–48 consequently, 
signaling activities of FGF-2 might be more efficient in 
muscles enriched with HS. On the other hand, other mecha-
nisms have also been suggested. The results from Wiedlocha 
et al49 indicate a receptor-independent mechanism for FGF-1 
stimulation of proliferation. This may be true for FGF-2 as 
both growth factors bind to similar receptors. Therefore, 
signals important for cell proliferation can be initiated either 
via the FGF receptors or independent of them. Furthermore, 
Quarto and Amalric50 reported that FGF-2 stimulated plas-
minogen activator expression in L6 rat myoblasts devoid of 
functional FGF receptor. They suggested that the signal is 
transduced through HS proteoglycans. This may also explain 
Table 5 expression of PAX-7 and FGF-2 on the messenger ribonucleic acid level, normalized to ACTB, and on the protein level in the 
breast muscle of chicken embryos without (–) or with gold nanoparticles and heparan sulfate
Treatment ANOVA
Without HS HS Effect Interaction
– Nano-Au – Nano-Au Nano-Au HS P
P SEM P SEM
PAX-7* 0.80 0.98 0.57 1.21 0.435 0.156 0.0086 0.358 0.845
FGF-2* 2.63 2.70 4.40 0.94 0.950 0.705 0.0024 0.117 0.806
FGF-2 pg/mg protein** 132 127 144 118 0.716 8.4 0.217 10.3 0.119
Notes: *Messenger ribonucleic acid level; **protein level.
Abbreviations: ANOVA, analysis of variance; hs, heparan sulfate; nano-Au, gold nanoparticles; seM, standard error of the mean.
AB
CD
20 µm 20 µm
20 µm 20 µm
Figure  5  Images  of  Pax-7  positive  nuclei,  shown  as  an  overlaid  image  of  4′,6-
diamidino-2-phenylindole-stained  nuclei  (blue)  and  Pax-7  nuclei  stained  with 
fluorescein isothiocyanate (green), in the cross-section of the breast muscle of a 
chicken embryo on day 20 of incubation visualized using a confocal microscope.   
(A) control, (B) gold nanoparticles, (C) heparan sulfate, and (D) gold nanoparticles 
and heparan sulfate complex.International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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the decreased mRNA expression of FGF-2 in HS-treated 
embryos, which could have been caused by increased effi-
ciency of FGF-2 and thereby diminished the requirement for 
the synthesis of this molecule.
TEM image analysis showed an increased number of 
satellite cells in the muscles of embryos treated with HS. The 
regeneration of muscle fibers in the postnatal period is highly 
dependent on the number of satellite cells formed during 
embryogenesis. Furthermore, the number of muscle satellite 
cells decreases with age. In chickens, in the late phase of muscle 
growth, it declines to less than 5% of the total number of muscle 
fibers.51 Thus, an increased pool of these cells during embryo-
genesis may protect from muscle atrophy later in life.52
To elucidate the effect of HS on muscle development, a 
number of cells containing protein Pax-7 and its gene expres-
sion at the mRNA level were estimated. Pax-7 is localized in 
the nucleus of satellite cells and is a recognized marker of these 
cells.7 Treatments with HS contributed to the increased number 
of Pax-7 positive cells and expression of the gene. In the present 
experiment, expression of FGF-2 at the mRNA level, close to 
hatching, was decreased in the HS groups. This may be related 
to the Pax-3 and Pax-7 genes, which are indirectly involved in 
the down regulation of FGF-2 via a feedback mechanism.53 
  Taking into consideration the fact that HS affected both the 
number of satellite cells as well as muscle cells, this indicates 
that HS modified the whole sequence of events during the matu-
ration of muscles, increasing the formation of muscle fibers, 
and increasing the formation and incorporation of satellite cells 
in the breast muscle at the end of embryogenesis.
Assessing the impact of nano-Au on muscle develop-
ment, it was measured that nano-Au increased the number of 
nuclei and enlarged the areas of fibers in the breast muscle. 
However, there was no effect of nano-Au on the number of 
satellite cells or on the number of muscle cells. These results 
may indicate that nano-Au could boost the number of nuclei 
in a single muscle fiber and/or increase the number of other 
cells. Certainly, more research is needed to elucidate the 
mechanisms of muscle fiber enlargement.
The present results have shown that cell and/or tissue 
requirements for functional compounds like sulfur-containing 
molecules may be a critical point for proper maturation and 
functioning of muscle. Moreover, nano-Au did not influence 
the homeostasis of the embryo organism, suggesting that 
they might be used as carriers of drugs and other bioactive 
  compounds. Although these results were obtained from 
chicken embryos, which develop quickly, they indicate the 
potential applicability of HS, nano-Au, and complexes of 
these materials for nutritional and therapeutic procedures.
Conclusion
Nano-Au and HS, administered in ovo to chicken embryos 
on the first day of embryogenesis, did not adversely affect 
mortality, organ weight, and homeostasis of the embryos 
by day 20 of embryonic development. HS improved the 
development and maturation of breast muscle by increasing 
the number of myocytes, satellite cells, and nuclei, and by 
increasing area of muscle fibers. Furthermore, the nano-
Au+HS complex contributed to the increased number of 
myocytes and nuclei, and enlarged area of muscle fibers. The 
results indicate that the administration of HS and nano-Au 
affects muscle development and that this effect is enhanced 
by conjugating HS with nano-Au.
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